Approval · Notice of Compliance 1783 · 1999
LESCOL: Notice of Compliance 1783
Issued November 17, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1783
- Date
- November 17, 1999
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised dosage
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LESCOL | Not yet assigned | — |
Medicinal ingredients
- FLUVASTATIN 20 MG per CAP
- FLUVASTATIN 40 MG per CAP